Search research articles
Contact Us
Filters
Showing results (81-90 of 114) with videos related to
Page
of 12
Sort By:
SLAS Discovery : Advancing Life Sciences R & D
|
June 11, 2021
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids
Nicholas Choo, Susanne Ramm, Jennii Luu, et al.
Scientific Reports
|
May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
Hui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
Oncogene
|
January 24, 2023
The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer
Xue Yang, Miguel I Cruz, Elizabeth V Nguyen, et al.
Cell Death Discovery
|
September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer
Carmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
EMBO Molecular Medicine
|
December 14, 2020
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death
Sophia Ceder, Sofi E Eriksson, Emarndeena H Cheteh, et al.
Transgenic Research
|
November 20, 2002
Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice
Melissa A Brown, Hans Nicolai, Kathy Howe, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 19, 2016
Metabolic profiling and in vitro assessment of anthelmintic fractions of Picria fel-terrae Lour
Rasika Kumarasingha, Avinash V Karpe, Sarah Preston, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2024
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Plos Pathogens
|
March 25, 2016
Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus Infection
Celine Deffrasnes, Glenn A Marsh, Chwan Hong Foo, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational Status
Madison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 114) with videos related to
Sort By:
Page
of 12
SLAS Discovery : Advancing Life Sciences R & D
|
June 11, 2021
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids
Nicholas Choo, Susanne Ramm, Jennii Luu, et al.
Scientific Reports
|
May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
Hui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
Oncogene
|
January 24, 2023
The pseudokinase NRBP1 activates Rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer
Xue Yang, Miguel I Cruz, Elizabeth V Nguyen, et al.
Cell Death Discovery
|
September 25, 2025
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer
Carmelo Cerra, Madeleine R C Tancock, Niko Thio, et al.
EMBO Molecular Medicine
|
December 14, 2020
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death
Sophia Ceder, Sofi E Eriksson, Emarndeena H Cheteh, et al.
Transgenic Research
|
November 20, 2002
Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice
Melissa A Brown, Hans Nicolai, Kathy Howe, et al.
International Journal for Parasitology. Drugs and Drug Resistance
|
September 19, 2016
Metabolic profiling and in vitro assessment of anthelmintic fractions of Picria fel-terrae Lour
Rasika Kumarasingha, Avinash V Karpe, Sarah Preston, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 17, 2024
miR-99b-5p, miR-380-3p, and miR-485-3p are novel chemosensitizing miRNAs in high-risk neuroblastoma
Holly Holliday, Jessica Yang, Eoin Dodson, et al.
Plos Pathogens
|
March 25, 2016
Genome-wide siRNA Screening at Biosafety Level 4 Reveals a Crucial Role for Fibrillarin in Henipavirus Infection
Celine Deffrasnes, Glenn A Marsh, Chwan Hong Foo, et al.
International Journal of Molecular Sciences
|
February 27, 2026
Differential Preclinical Efficacy of Combined CDK4/6 and MEK Inhibition in Low-Grade Serous Ovarian Carcinoma Based on <i>KRAS/NF1</i> Mutational Status
Madison Bittner, Marta Llaurado Fernandez, Joshua Hoenisch, et al.
Page
of 12